High dose chemotherapy and autologous stem cell transplantation for metastatic breast cancer: is there a place?

被引：0
|
作者：
Stadtmauer, EA [1 ]
机构：
[1] Univ Penn, Ctr Canc, Bone Marrow & Stem Cell Transplant Program, Philadelphia, PA 19104 USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2003年 / 81卷
关键词：
high dose chemotherapy; metastatic breast cancer; stem cell transplant;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Seven comparative trials with over 2000 patients enrolled show no definitive evidence that high dose chemotherapy with stem cell support offers a survival advantage for metastatic breast cancer over conventional dose chemotherapy. Though numbers are low and small differences may exist particularly in subsets of patients, the duration of follow-up is adequate to make the likelihood of a late benefit low. High dose chemotherapy with stem cell transplantation does not have a place in the treatment of metastatic breast cancer outside of clinical trials.
引用
收藏
页码：S111 / S115
页数：5
相关论文
共 50 条
  • [31] High-dose chemotherapy and autologous blood stem cell transplantation in children with metastatic neuroblastoma
    Kai, T
    Ishii, E
    Matsuzaki, A
    Inaba, S
    Suita, S
    Ueda, K
    ACTA PAEDIATRICA JAPONICA, 1997, 39 (01): : 54 - 60
  • [32] High-dose chemotherapy followed by autologous stem cell transplantation in non-metastatic high-risk breast cancer: a systematic review
    Herrmann-Frank, A.
    Sturtz, S.
    Lerch, C.
    Richter, B.
    Bartel, C.
    Droste, S.
    Lange, S.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S87 - S87
  • [33] Is high-dose chemotherapy with autologous hematopoietic stem cell transplantation in breast cancer patients a done deal?
    Cheng, Yee Chung
    Ueno, Naoto T.
    WOMENS HEALTH, 2010, 6 (04) : 481 - 485
  • [34] High-dose chemotherapy and autologous peripheral blood stem cell transplantation in metastatic breast cancer.: Updated results of a single center
    Okan, K.
    Komurcu, S.
    Arpaci, F.
    Ozet, A.
    Beyzadeoglu, M.
    Ulutin, C.
    Ataergin, S.
    EJC SUPPLEMENTS, 2005, 3 (02): : 132 - 132
  • [35] High-dose chemotherapy and autologous peripheral blood stem cell transplantation for primary breast cancer refractory to neoadjuvant chemotherapy
    N T Ueno
    S Konoplev
    T A Buchholz
    T Smith
    G Rondón
    P Anderlini
    S A Giralt
    J L Gajewski
    M L Donato
    M Cristofanilli
    R E Champlin
    Bone Marrow Transplantation, 2006, 37 : 929 - 935
  • [36] High-dose chemotherapy and autologous peripheral blood stem cell transplantation for primary breast cancer refractory to neoadjuvant chemotherapy
    Ueno, NT
    Konoplev, S
    Buchholz, T
    Smith, T
    Rondón, G
    Anderlini, P
    Giralt, S
    Gajewski, JL
    Donato, ML
    Cristofanilli, M
    Champlin, R
    BONE MARROW TRANSPLANTATION, 2006, 37 (10) : 929 - 935
  • [37] High dose chemotherapy with autologous stem cell transplantation for patients with germ-cell cancer
    Popovic, L.
    Jovanovic, D.
    Donat, D.
    Petrovic, D.
    Roganovic, T.
    Lotz, J. P.
    JOURNAL OF BUON, 2013, 18 (01): : 290 - 291
  • [38] Tandem high-dose chemotherapy with autologous peripheral blood stem cell support in metastatic breast cancer.
    Myhand, R
    Atkins, M
    Coleman, T
    Reeb, B
    Smith, D
    Alexander, B
    Vukelja, SJ
    BLOOD, 1997, 90 (10) : 4571 - 4571
  • [39] High-dose chemotherapy and autologous stem cell transplant in women with de novo chemosensitive metastatic breast cancer
    Stemmer, SM
    Hardan, I
    Brenner, HJ
    Rizel, S
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2004, 27 (03): : 250 - 255
  • [40] High-dose chemotherapy with autologous stem cell support in patients with breast cancer
    Rahman, ZU
    Hortobagyi, GN
    Buzdar, AU
    Champlin, R
    CANCER TREATMENT REVIEWS, 1998, 24 (04) : 249 - 263
12345